News
In an exclusive chat with Deccan Chronicle, Kshemavana’s Chief Wellness Officer warns against drug abuse, nutraceutical ...
Flinders Health and Medical Research Institute researchers, along with colleagues in the UK and U.S., have linked brighter ...
Revascularization of all vessels with stenosis was linked to lower rates of death, another MI, and further revascularization ...
Despite the global implementation of clinical algorithms designed to predict atherosclerotic cardiovascular disease based on ...
In STEMI-induced cardiogenic shock, a microaxial flow pump can unload the heart by reducing native cardiac output and ...
6d
HealthDay on MSNEmpagliflozin Has Kidney Protective Effects in Acute Myocardial InfarctionTotal adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function.
Individuals with IBD, especially CD, have an increased risk for myocardial infarction, ischemic heart disease, cerebrovascular accident, and major adverse cardiovascular events.
Acute MI mortality has fallen, yet deaths from other diseases, including heart failure and hypertension, are on the rise.
A new study highlights a sharp decline in deaths from heart attacks, while showing a significant rise in mortality from other heart conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results